000 01849 a2200553 4500
005 20250517093119.0
264 0 _c20180822
008 201808s 0 0 eng d
022 _a1468-2060
024 7 _a10.1136/annrheumdis-2016-209248
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerheul, M K
245 0 0 _aAnti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation.
_h[electronic resource]
260 _bAnnals of the rheumatic diseases
_c08 2016
300 _a1575-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Letter
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnimals
650 0 4 _aArthritis, Rheumatoid
_ximmunology
650 0 4 _aAutoantibodies
_ximmunology
650 0 4 _aAutoantigens
_ximmunology
650 0 4 _aBiomarkers
_xblood
650 0 4 _aCarbamates
_ximmunology
650 0 4 _aCase-Control Studies
650 0 4 _aDisease Progression
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aReference Values
650 0 4 _aRenal Insufficiency
_xblood
650 0 4 _aSensitivity and Specificity
650 0 4 _aSmoking
_xblood
700 1 _avan Erp, S J H
700 1 _avan der Woude, D
700 1 _aLevarht, E W N
700 1 _aMallat, M J K
700 1 _aVerspaget, H W
700 1 _aStolk, J
700 1 _aToes, R E M
700 1 _avan der Meulen-de Jong, A E
700 1 _aHiemstra, P S
700 1 _avan Kooten, C
700 1 _aTrouw, L A
773 0 _tAnnals of the rheumatic diseases
_gvol. 75
_gno. 8
_gp. 1575-6
856 4 0 _uhttps://doi.org/10.1136/annrheumdis-2016-209248
_zAvailable from publisher's website
999 _c25974068
_d25974068